Implementation of a Risk-Stratified Opioid and Benzodiazepine Weaning Protocol in a Pediatric Cardiac ICU

Rambod Amirnovin1, L Nelson Sanchez-Pinto2, Carol Okuhara3

  • 1Department of Anesthesiology and Critical Care Medicine, Children's Hospital Los Angeles, Los Angeles, CA.

Insights

A new protocol reduced opioid and benzodiazepine exposure in critically ill children with heart disease. This led to shorter treatment durations, fewer withdrawal symptoms, and reduced hospital stays.

Area of Science:

  • Pediatric critical care medicine
  • Cardiology
  • Pharmacology

Background:

  • Opioids and benzodiazepines are standard for analgesia and sedation in critically ill children with cardiac conditions.
  • These medications carry risks, including delirium, dependence, withdrawal, and potential neurodevelopmental issues.

Purpose of the Study:

  • To implement a risk-stratified weaning protocol for opioids and benzodiazepines.
  • To reduce medication exposure in pediatric patients with cardiac disease.

Main Methods:

  • A prospective pre- and postinterventional study design was used.
  • An evidence-based opioid and benzodiazepine weaning protocol was implemented using educational and quality improvement methods.
  • The study included critically ill children (≤21 years) with cardiac disease receiving scheduled opioids ± benzodiazepines for ≥7 days.

Main Results:

  • The postintervention group showed significantly shorter durations of opioid (19.0 vs 30.0 days) and benzodiazepine (5.3 vs 22.7 days) use.
  • Withdrawal occurrence decreased (4.9% vs 14.1%) despite shorter weaning durations.
  • Hospital length of stay was reduced by 8 days (34 vs 42 days).

Conclusions:

  • Implementation of a risk-stratified weaning protocol effectively reduced opioid and benzodiazepine exposure in critically ill pediatric cardiac patients.
  • The protocol led to decreased withdrawal symptoms and a shorter hospital length of stay.
  • This approach offers a strategy to mitigate adverse effects associated with prolonged sedative and analgesic use in this vulnerable population.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.1K
Stratified Sampling Method01:16

Stratified Sampling Method

Sampling is a technique to select a portion (or subset) of the larger population and study that portion (the sample) to gain information about the population. The sampling method ensures that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a stratified sample, divide the population into groups called strata and then take a...
15.4K
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
910
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.4K
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.4K
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.5K